ClinicalTrials.govpublic full text
A Study of Niraparib in Patients With Ovarian Cancer Who Have Received Three or Four Previous Chemotherapy Regimens
ovarian neoplasms, ovarian cancer, gbrcamut, brca, parp inhibitor, hrd, serous epithelial, fallopian tube, primary peritoneal, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 870642
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.